This switch between stem cell quiescence and proliferation is a central but poorly understood issue in stem cell biology. Drosophila larval neural stem cells, neuroblasts, enter into quiescence at the end of embryogenesis and exit quiescence to be reactivated at early larval stages. Upon food stimulation, glial cells secret insulin to activate the insulin/IGF pathway in underlying neuroblasts and promote their proliferation growth and proliferation from quiescence. However, the intrinsic regulators that control neuroblast reactivation are not well-known. During an RNA interference (RNAi) screen, we uncover Chromator (Chro) as a novel regulator of neuroblast reactivation. In chro RNAi knock-down or chro mutant, neuroblasts displayed a cellular extension and most neuroblasts failed to incorporate with EdU (5-ethynyl-2'-deoxyuridine), suggesting that loss of Chro function induces neuroblast quiescence. We find that Chro is not only required for neuroblast reactivation, but important for maintaining neuroblast in a proliferative state. We further show that Chro functions downstream of insulin/IGF pathway during neuroblast reactivation. From a genome-wide in vivo profiling, we identified candidate genes that function downstream of Chro during neuroblast reactivation. Our data suggest that Chro is a critical intrinsic regulator of neuroblast reactivation. The pituitary gland is the master regulator of a multitude of physiological functions, from lactation and fertility to metabolisms and growth. The precise molecular mechanism that dictates pituitary development and adult organ homoeostasis to control endocrine challenges is not known. Pituitary progenitor/stem cells (PPSCs) have been shown to be important in organ development and to be able to mobilise and regenerate specific cell types upon physiological demand. How this mechanism is accomplished in not understood.
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In this study we use gene expression and double immunostaining to show that Ephrin-B2 is expressed by the PPSCs throughout development and adulthood. Using a reporter GFP knock-in under the Ephrin-B2 (Efnb2) regulatory elements, we observed that cells expressing Efnb2 are localised in the marginal zone of the anterior pituitary and express all PPSCs markers such as Nestin, Sox2, Sox9 and SCA1. Efnb2 negatively regulates PPSCs proliferation and differentiation, leading to multiple phenotypes, including hyperplasia of the anterior pituitary, hypopituitarism, delayed terminal differentiation of hormone-producing cells and endocrine deficiencies later in life.
A proportion of Efnb2 pituitary-specific knock-out animals exhibits dwarfism, eye and brain abnormalities that closely resemble features of the human congenital birth defect septo-optic dysplasia. Our data suggest for the first time that Efnb2 is a critical regulator of pituitary development in a multistep fashion, firstly by controlling early morphogenesis of the anterior pituitary gland and secondly by maintaining the progenitor pool to provide a response to endocrine challenges throughout life. 
University of Helsinki, Finland
After birth, stem cells (SCs) remain as the source of reparative and regenerative potential in various tissue, including the cervical loop in the rodent incisor tooth in which epithelial SCs are surrounded by their progeny and mesenchymal cells that regulate their survival, proliferation and differentiation through complex interactions that are not yet fully elucidated. Tooth epithelial SCs can be identified by Sox2 expression and they differentiate into several lineages, including enamel-secreting ameloblasts, identified by the expression of ameloblast-specific genes including Enamelin. Objective: This study is designed to test the in vitro growth potential of epithelial SCs and their ability to differentiate into ameloblasts. Methodology: Epithelial SCs were obtained by FACS sorting from Sox2-GFP transgenic reporter mice and cultured under non-adherent conditions in the presence of various proteins in a single or multiple combinations. Results: When cultured under non-adherent conditions Sox2-GFP+ cells expand in number and generate 3D spherical structures in which they maintain Sox2 expression for the restricted period of time. Analysis of the various single, double and triple growth factor combinations demonstrated that the simultaneous addition of Shh and Noggin amplified the positive effect on sphere formation and expression of SC markers, including Sox2, Lgr5, Bmi1 and Prom1. Other proteins either alone or in various combinations showed positive effects on the sphere formation, but had variable effects on the expression of SC markers. In addition, there was an increase in the number of transit-amplifying cells expressing Shh and P-cadherin. Conclusions: Our non-adherent culture method allows expansion of Sox2+ epithelial SCs into spherical and heterogeneous 3D structures which molecularly resemble the incisor epithelial SC niche in vivo, judged by the presence of progeny markers Shh and P-cadherin. 
